Literature DB >> 10960641

Contrast-enhanced, three-dimensional power Doppler sonography for differentiation of adnexal masses.

S Kupesic1, A Kurjak.   

Abstract

OBJECTIVE: To investigate the potential usefulness of contrast-enhanced, three-dimensional power Doppler sonography in the differentiation of benign and malignant adnexal lesions.
METHODS: A total of 45 patients with complex adnexal lesions of uncertain malignancy at transvaginal B mode and/or color Doppler sonography were prospectively evaluated with three-dimensional power Doppler sonography before and after injection of contrast agent. Presence of a penetrating pattern and a mixed penetrating and peripheral pattern suggested adnexal malignancy. All the results were compared with histopathology.
RESULTS: There were 12 cases of ovarian malignancy and 33 benign adnexal lesions. Of the 12 ovarian cancers, seven (58. 3%) showed vascular distribution suggestive of malignancy at nonenhanced three-dimensional power Doppler sonography. After injection of contrast agent, a penetrating vascular pattern and/or a mixed penetrating and peripheral pattern were detected in all cases of ovarian malignancy. One cystadenofibroma demonstrated penetrating vessels at initial scan, whereas two benign lesions (fibroma and cystadenofibroma) were misdiagnosed as malignant at contrast-enhanced, three-dimensional power Doppler sonography. The use of a contrast agent with three-dimensional power Doppler sonography showed diagnostic efficiency (95.6%) that was superior to that of nonenhanced three-dimensional power Doppler sonography (86. 7%).
CONCLUSION: Contrast-enhanced, three-dimensional power Doppler sonography provides better visualization of tumor vascularity in complex adnexal masses. If used together with three-dimensional morphologic ultrasound assessment, enhanced three-dimensional power Doppler imaging might precisely discriminate benign from malignant adnexal lesions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10960641     DOI: 10.1016/s0029-7844(00)00923-6

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  9 in total

1.  Notice of retraction: "What do contrast media add to three-dimensional power Doppler evaluation of adnexal masses?" (Croat Med J. 2000;41:257-61).

Authors:  Matko Marusic
Journal:  Croat Med J       Date:  2007-04       Impact factor: 1.351

2.  Parametric mapping of contrasted ovarian transvaginal sonography.

Authors:  Katrina Korhonen; Ryan Moore; Andrej Lyshchik; Arthur C Fleischer
Journal:  Ultrasound Q       Date:  2015-06       Impact factor: 1.657

3.  Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy.

Authors:  Theresa M Busch; Xiaoman Xing; Guoqiang Yu; Arjun Yodh; E Paul Wileyto; Hsing-Wen Wang; Turgut Durduran; Timothy C Zhu; Ken Kang-Hsin Wang
Journal:  Photochem Photobiol Sci       Date:  2009-10-15       Impact factor: 3.982

4.  Clinical value of TV-CDS combined with serum tumor markers in diagnosis of ovarian cancer.

Authors:  Chunying Yu; Ting Dou; Yun Liu; Ruirong Liu
Journal:  Oncol Lett       Date:  2020-06-05       Impact factor: 2.967

5.  Diagnostic value of contrast-enhanced ultrasonography in the characterization of ovarian tumors().

Authors:  L M Sconfienza; N Perrone; A Delnevo; F Lacelli; C Murolo; N Gandolfo; G Serafini
Journal:  J Ultrasound       Date:  2009-10-13

6.  Early detection of ovarian cancer with conventional and contrast-enhanced transvaginal sonography: recent advances and potential improvements.

Authors:  Arthur C Fleischer; Andrej Lyshchik; Makiko Hirari; Ryan D Moore; Richard G Abramson; David A Fishman
Journal:  J Oncol       Date:  2012-04-26       Impact factor: 4.375

Review 7.  Advances in tumor screening, imaging, and avatar technologies for high-grade serous ovarian cancer.

Authors:  Anders W Ohman; Noor Hasan; Daniela M Dinulescu
Journal:  Front Oncol       Date:  2014-11-18       Impact factor: 6.244

8.  Value of Transvaginal Two-Dimensional Contrast-Enhanced Ultrasonography in Diagnosing Atypical Ovarian Corpus Luteum Hematoma.

Authors:  Hui Liu; Hong Xiang; Ruixue Mu; Palida Tuoerhan; Qianqian Zeng; Huili Zhou; Rong Hu; Gulinaer Shahai
Journal:  Biomed Res Int       Date:  2018-10-09       Impact factor: 3.411

9.  A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model of hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery.

Authors:  Yu Zou; Chuan-Gen Guo; Zheng-Gang Yang; Jun-Hui Sun; Min-Ming Zhang; Cai-Yun Fu
Journal:  Drug Des Devel Ther       Date:  2016-03-24       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.